Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-10

Clinical Trial Update: Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo [NA]

View source ↗

Summary

A completed bioequivalence study comparing a clindamycin phosphate 1.2% and tretinoin 0.025% topical gel to Ziana and placebo for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN PHOSPHATE (Clindamycin phosphate)
  • TRETINOIN (TRETINOIN)
  • ZIANA (CLINDAMYCIN PHOSPHATE AND TRETINOIN)

Snippet

Sponsor: Actavis Mid-Atlantic LLC | Conditions: MILD TO SEVERE ACNE VULGARIS | NA | Status: COMPLETED